Steven Nissen, MD

• Principal Investigator, Global Cardiovascular Innovation Center, Cleveland Clinic, 2006
• Director, Joseph J. Jacobs Center for Thrombosis and Vascular Biology, Cleveland Clinic
• Member, National Institutes of Health Level 1 Working Group on Clinical Trial Design National Heart, Lung, and Blood Institute (NHLBI), 2006
• National Government Service: Presently serves as Special Government Employee as periodic advisor to the U.S. Food and Drug Administration (FDA).
• Chairman, Cardiovascular Renal Drugs Advisory Committee, Department of Health and Human Resources, FDA, 2004 - 2005
• Member, Cardiovascular Renal Drugs Advisory Committee, Department of Health and Human Resources, FDA, 2000 - 2004
• Medical Director, Cleveland Clinic Cardiovascular Coordinating Center - an organization that directs multicenter clinical trials, 2001 - 2006

• Intensive Care Units Committee, University of Kentucky Medical Center, 1983-1992
• Aeromedical Patient Care for the University of Kentucky, 1987-1992
• Certification - Cardiovascular Medicine, American Board of Internal Medicine, 1983
• Certification - American Board of Internal Medicine, 1979
• Certification - National Board of Medical Examiners, 1979

• Best Doctors, Cleveland Magazine, 2008, 2014
• America Top Doctors, Castle Connolly, 2014
• Golden Achievement for Medicine Award, Golden Age Centers of Greater Cleveland, 2012
• Simon Dack Award for Outstanding Scholarship, Awarded by Journal of American College of Cardiology Editorial Board and the American College of Cardiology, 2011
• Most Interesting People, Cleveland Magazine, 2010
• 100 Most Influential People in the World Scientists and Thinkers, TIME Magazine, 2007
• Country 30 Most Powerful Forces in Business and Finance, Smart Money, 2007
• President, American College of Cardiology, a 34,000-member, non-profit, professional medical society whose mission is to advocate for quality cardiovascular care - through education, research promotion, development and application of standards and guidelines - and to influence health care policy, March 2006 thru March 2007
• Honorary Member of the Japanese College of Cardiology (JCC), 2007
• Award for Outstanding Contributions to Cardiovascular Research from the Gill Heart Institute of the University of Kentucky, 2004
• Outstanding Scientist Award, Cleveland Clinic, 2004
• Three-time recipient of the Outstanding Teacher Award, Fellows of Cardiovascular Medicine at Cleveland Clinic (2004, 1998, 1994)
• Dr. Nissen has received a number of additional honors and recognitions

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2025-07-03, Dr. Nissen has reported no financial relationship with industry that is applicable to this listing.

In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.